dicentrinone has been researched along with chelerythrine in 1 studies
| Studies (dicentrinone) | Trials (dicentrinone) | Recent Studies (post-2010) (dicentrinone) | Studies (chelerythrine) | Trials (chelerythrine) | Recent Studies (post-2010) (chelerythrine) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 1,115 | 1 | 269 |
| Protein | Taxonomy | dicentrinone (IC50) | chelerythrine (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 1.2 | |
| Cholinesterase | Homo sapiens (human) | 8.58 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.55 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.45 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.566 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, T; Pati, S; Swain, SS | 1 |
1 other study(ies) available for dicentrinone and chelerythrine
| Article | Year |
|---|---|
Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |